The role of IL‐6 in SSc is particularly well‐documented, with a substantial experimental evidence base34 and clinical observations tying serum IL‐6 levels to manifestations such as skin, muscle, and cardiac involvements.35, 36. Here, IL6 is linked to systemic sclerosis.